|
IMPACT
Volume 6
 007 PDF 56KB |
November
2012 |
MHRA advice for Simvastatin
Atorvastatin versus simvastatin costs
Changes to the prescribing and availability of Epanutin
Branded prescribing for renal patients |
|
IMPACT
Volume 6
006
PDF 78KB |
September
2012 |
Oral Nutritional Supplements - Which products should I use?
MHRA warnings for dabigatran
MHRA warnings for domperidone |
|
IMPACT
Volume 6
005
PDF 59KB |
August
2012 |
Security of prescription forms
Rivaroxaban for use in atrial fibrillation
RESPeRATE® - Non-formulary
Dutasteride price increase
Jext® - adrenaline autoinjector |
|
IMPACT
Volume 6
004
PDF 64KB |
June
2012 |
Scottish Quality Prescribing Initiative
High dose steroid inhaler prescribing
SIGN 101 Management of Asthma - Stepping Down Therapy
Admission Rates For COPD and Asthma versus Steroid Inhaler Prescribing
Inhaled Steroids in the Management of COPD - NICE Guideline |
|
IMPACT
Volume 6
003
PDF 90KB |
May
2012 |
Antibiotics - the need to reduce volume of prescribing
SAPG Primary Care Prescribing Indicator report 2010/11
GP National audit tool for management of common infections
Management of upper respiratory tract infections |
|
IMPACT
Volume 6
002
PDF 66KB |
February
2012 |
Special Update
Calcium and Vitamin D Supplementation in the Prevention of Fracture: Practical Prescribing |
|
IMPACT
Volume 6
001
PDF 62KB | January
2012 |
NICE Guideline on Hypertension 2011
NHSG Primary Care Empirical Antibiotic Guidelines
Formulary Group Decision - November 2011
ScriptSwitch update |
